ABC | Volume 111, Nº3, September 2018

Original Article Radaelli et al Secondary dyslipidemia in obese children Arq Bras Cardiol. 2018; 111(3):356-361 Author contributions Conception and design of the research: Radaelli G, Pellanda LC; Acquisition of data: Radaelli G, Sausen G; Analysis and interpretation of the data and Writing of the manuscript: Radaelli G, Cesa CC; Obtaining financing: Radaelli G; Critical revision of the manuscript for intellectual content: Radaelli G, Sausen G, Cesa CC, Portal VL, Pellanda LC. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This article is part of the thesis of Doctoral submitted by Graciane Radaelli, from Instituto de Cardiologia do Rio Grande do Sul. Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors. 1. Pencina MJ, Navar-Boggan AM, D’Agostino RB Sr, Williams K, Neely B, Sniderman AD, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370(15):1422-31. 2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38-360. Erratum in: Circulation. 2016;133(15):e599. 3. Kit BK, Kuklina E, Carrol MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169(3):272-9. 4. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11-25. 5. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213-56. 6. Eiland LS, Luttrell PK. Use of statins for dyslipidemia in the pediatric population. J Pediatr Pharmacol Ther. 2010;15(3):160-72. 7. D’AdamoE,GuardamagnaO,ChiarelliF,BartuliA,LiccardoD,FerrariF,etal. Atherogenic dyslipidemia and cardiovascular risk factors in obese children. Int J Endocrinol. 2015;2015:912047. 8. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr. 1995;126(5 Pt 1):690-5. 9. Stan S, Levy E, Delvin EE, Hanley JA, Lamarche B, O’Loughlin J, et al. Distribution of LDL particle size in a population-based sample of children and adolescents and relationshipwith other cardiovascular risk factors. Clin Chem. 2005;51(7):1192-200. 10. BirchLL.Developmentof foodpreferences.AnnuRevNutr.1999;19:41-62. 11. Kelder SH, Perry CL, Klepp KI, Lytle LL. Longitudinal tracking of adolescent smoking, physical activity, and food choice behaviors. Am J Public Health. 1994;84(7):1121-6. 12. Hiddink GJ, Hautvast JG, van Woerkum CM, Fieren CJ, Van’t Hof MA. Nutrition guidance by primary-care physicians: perceived barriers and low involvement. Eur J Clin Nutr. 1995;49(11):842-51. 13. Levine BS, Wigren MM, Chapman DS, Kerner JF, Bergman RL, Rivlin RS. A national survey of attitudes and practices of primary-care physicians relating to nutrition: strategies for enhancing the use of clinical nutrition in medical practice. Am J Clin Nutr. 1993;57(2):115-9. 14. Krebs NF, Himes JH, JacobsonD, Nicklas TA, Guilday P, StyneD. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007;120 Suppl 4:S193-228. 15. Kushner RF. Barriers to providing nutrition counseling by physicians: a survey of primary care practitioners. Prev Med. 1995;24(6):546-52. 16. Hiddink GJ, Hautvast JG, Van Woerkum CM, Fieren CJ, Van‘t Hof MA. Driving forces for and barriers to nutrition guidance practices of Dutch primary-care physicians. J Nutr Educ. 1997;29(1):36-41. 17. BraamskampM,WijburgFA,WiegmanA.Drugtherapyofhypercholesterolaemia in children and adolescents. Drugs. 2012;72(6):759-72. 18. Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, et al; European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014;35(32):2146-57. 19. Humphries SE, Norbury G, Leigh S, Hadfield SG, Nair D.What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Curr Opin Lipidol. 2008;19(4):362-8. 20. Li S, Chen W, Srinivasan SR, Xu J, Berenson GS. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am J Epidemiol. 2012;176 Suppl 7:S142-9. 21. Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36(36):2425-37. 22. Descamps OS, Tenoutasse S, Stephenne X, Gies I, Beauloye V, Lebrethon MC, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis. 2011;218(2):272-80. 23. U.S. Food&Drug-Administration. Federal drug authority. [Accessed in 2016 July 27]. Available from: http://www.fda.gov . 24. O’Brien EC, Roe MT, Fraulo ES, Peterson ED, Ballantyne CM, Genest J, et al. Rationale and design of the familial hypercholesterolemia foundation cascade screening for awareness and detection of familial hypercholesterolemia registry. AmHeart J. 2014;167(3):342-9. 25. Belay B, Belamarich PF, Tom-Revzon C. The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics. 2007;119(2):370-80. References 359